Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Avita Medical Inc. (RCEL) vs TriSalus Life Sciences, Inc. (TLSI)

Avita Medical Inc. and TriSalus Life Sciences, Inc. are both Medical Devices companies. Avita Medical Inc. and TriSalus Life Sciences, Inc. are of similar size ($303.6M and $289.1M). TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against 1.00%. Avita Medical Inc. has the higher net margin (−57.0% vs −127.0%) and the lower return on invested capital (−306.2% vs 0.00%). Across the 16 metrics below, Avita Medical Inc. leads on 9 and TriSalus Life Sciences, Inc. on 7.

Valuation

Metric RCEL TLSI Medical Devices median
P/E n/m n/m 22.18
P/S 0.24 5.61 2.70
P/B n/m 38.63 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 1.26 5.33 2.38
Earnings yield (242.47%) (29.95%) (8.22%)
Free cash flow yield (139.60%) (9.48%) (7.80%)

Profitability

Metric RCEL TLSI Medical Devices median
Gross margin 81.56% 85.79% 56.01%
Operating margin (49.79%) (67.68%) (15.03%)
Net margin (56.96%) (127.00%) (20.40%)
Free cash flow margin (33.38%) (51.56%) (7.24%)
Return on equity 211.55% 889.44% (15.32%)
Return on assets (81.36%) (110.34%) (19.72%)
Return on invested capital (306.20%) 0.00% (10.33%)

Growth

Metric RCEL TLSI Medical Devices median
Revenue growth (TTM) 1.00% 25.25% 8.80%
EPS growth (last fiscal year) 27.02% (40.46%) —
Revenue growth, 5-year CAGR 19.63% — 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RCEL TLSI Medical Devices median
Debt to equity (1.68) 5.05 0.07
Current ratio 0.41 5.35 2.50
Net debt to EBITDA (0.60) (0.50) 0.49

Dividend

Metric RCEL TLSI Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric RCEL TLSI Medical Devices median
Market cap 289.14m 303.56m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack